Compile Data Set for Download or QSAR
Report error Found 79 Enz. Inhib. hit(s) with all data for entry = 9004
LigandPNGBDBM435159(US10584134, Example 2-5)
Affinity DataEC50:  100nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  100nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435195(US10584134, Example 3-18)
Affinity DataEC50:  100nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435160(US10584134, Example 2-8 | US10584134, Example 2-7)
Affinity DataEC50:  100nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435176(US10584134, Example 3-1)
Affinity DataEC50:  100nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435142(US10584134, Example 1-1)
Affinity DataEC50:  100nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435180(US10584134, Example 3-5)
Affinity DataEC50:  200nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435150(US10584134, Example 1-6)
Affinity DataEC50:  200nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435155(US10584134, Example 2-2)
Affinity DataEC50:  300nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  300nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435211(US10584134, Example 3-32)
Affinity DataEC50:  300nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  300nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435210(US10584134, Example 3-31)
Affinity DataEC50:  300nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435209(US10584134, Example 3-30)
Affinity DataEC50:  400nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  400nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435167(US10584134, Example 2-14)
Affinity DataEC50:  400nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435194(US10584134, Example 3-17)
Affinity DataEC50:  400nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  500nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435160(US10584134, Example 2-8 | US10584134, Example 2-7)
Affinity DataEC50:  500nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435204(US10584134, Example 3-26)
Affinity DataEC50:  600nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435183(US10584134, Example 3-8)
Affinity DataEC50:  600nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435143(US10584134, Example 1-2)
Affinity DataEC50:  600nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  700nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435219(US10584134, Example 3-41)
Affinity DataEC50:  700nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435151(US10584134, Example 1-7)
Affinity DataEC50:  700nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435184(US10584134, Example 3-9)
Affinity DataEC50:  700nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435188(US10584134, Example 3-12)
Affinity DataEC50:  700nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435216(US10584134, Example 3-38)
Affinity DataEC50:  700nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435147(US10584134, Example 1-3)
Affinity DataEC50:  700nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435196(US10584134, Example 3-19)
Affinity DataEC50:  700nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435156(US10584134, Example 2-3)
Affinity DataEC50:  800nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435208(US10584134, Example 3-29)
Affinity DataEC50:  800nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  800nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435181(US10584134, Example 3-6)
Affinity DataEC50:  800nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435179(US10584134, Example 3-4)
Affinity DataEC50:  800nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  900nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435178(US10584134, Example 3-3)
Affinity DataEC50:  900nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435157(US10584134, Example 2-4)
Affinity DataEC50:  1.00E+3nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435222(US10584134, Example 3-44)
Affinity DataEC50:  1.00E+3nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435162(US10584134, Example 2-9)
Affinity DataEC50:  1.00E+3nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435182(US10584134, Example 3-7)
Affinity DataEC50:  1.10E+3nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435197(US10584134, Example 3-20)
Affinity DataEC50:  1.10E+3nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435185(US10584134, Example 3-10)
Affinity DataEC50:  1.20E+3nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435164(US10584134, Example 2-11)
Affinity DataEC50:  1.20E+3nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435199(US10584134, Example 3-22)
Affinity DataEC50:  1.30E+3nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435149(US10584134, Example 1-5)
Affinity DataEC50:  1.40E+3nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435191(US10584134, Example 3-14)
Affinity DataEC50:  1.50E+3nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  1.60E+3nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435225(US10584134, Example 3-47)
Affinity DataEC50:  1.70E+3nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435198(US10584134, Example 3-21)
Affinity DataEC50:  1.70E+3nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

Displayed 1 to 50 (of 79 total ) | Next | Last >>
Jump to: